Evidence map›Paper›PMID 41414667›Full record

ArticleNucleic acids research2025

Type I-Fv and engineered type IV-A1 CRISPR-Cas effectors facilitate genome reduction in Escherichia coli.

Nathalie Klein, Mariana Sanchez-Londono, Meral M Kara, José Vicente Gomes-Filho, Samuel Novak, Karim H Kholeif, Lukas Pekarek, Neva Caliskan, Lennart Randau

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nathalie KleinDepartment of Biology, Philipps-Universität Marburg, Hans-Meerwein-Straße 6, 35043 Marburg, Germany.
Mariana Sanchez-LondonoDepartment of Biology, Philipps-Universität Marburg, Hans-Meerwein-Straße 6, 35043 Marburg, Germany.
Meral M KaraDepartment of Biology, Philipps-Universität Marburg, Hans-Meerwein-Straße 6, 35043 Marburg, Germany.
José Vicente Gomes-FilhoDepartment of Biology, Philipps-Universität Marburg, Hans-Meerwein-Straße 6, 35043 Marburg, Germany.
Samuel NovakHelmholtz Institute for RNA-based Infection Research (HIRI-HZI), Josef-Schneider-Straße 2, 97080 Würzburg, Germany.
Karim H KholeifDepartment of Biology, Philipps-Universität Marburg, Hans-Meerwein-Straße 6, 35043 Marburg, Germany.
Lukas PekarekHelmholtz Institute for RNA-based Infection Research (HIRI-HZI), Josef-Schneider-Straße 2, 97080 Würzburg, Germany.
Neva CaliskanHelmholtz Institute for RNA-based Infection Research (HIRI-HZI), Josef-Schneider-Straße 2, 97080 Würzburg, Germany.
Lennart RandauDepartment of Biology, Philipps-Universität Marburg, Hans-Meerwein-Straße 6, 35043 Marburg, Germany.ORCID 0000-0002-2780-2076

Funding

DFG 360987069DFG 505997786German Research FoundationHelmholtz Association INST 93/1021-1 FUGGMicrocosm Earth CenterPhilipps-Universität Marburg
6 · The paper itself

Abstract

Class 1 CRISPR-Cas systems utilize multi-subunit effector ribonucleoprotein complexes to identify and target DNA. Upon recognition, type I systems recruit the helicase/nuclease Cas3 for DNA degradation, while type IV-A systems use the helicase CasDinG for transcriptional repression. Here, we developed two recombinant class 1 CRISPR-Cas genome editing tools for inducing large genomic deletions: the compact type I-Fv (also termed I-F2) system from Shewanella putrefaciens and the type IV-A1 system from Pseudomonas oleovorans. In the latter, CasDinG was engineered to include a C-terminal HNH nuclease domain, conferring DNA cleavage activity and enabling analysis of CasDinG processivity. Whole-genome sequencing of Escherichia coli BL21-AI was used to monitor genome reduction and DNA repair mechanisms in response to CRISPR-Cas-induced damage. Small deletions were flanked by microhomologies, consistent with repair via alternative end joining, whereas deletions larger than 10 kb consistently terminated at nearby IS1 elements, implicating these sequences in the repair process. This study introduces compact type I and engineered type IV-A genome editing tools with distinct protospacer-adjacent motif requirements and provides new insights into CasDinG evolution and the DNA repair pathways engaged during CRISPR-Cas-mediated genome editing.

Indexed as

CRISPR-Cas SystemsEscherichia coliGene EditingGenome, BacterialBacterial ProteinsCRISPR-Associated ProteinsDNA RepairBacterial ProteinsCRISPR-Associated Proteins

Identifiers

PMID41414667
PMCPMC12714560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.